Press Releases AllArgonaut TherapeuticsCelleron TherapeuticsEvents & PresentationsPress Releases Celleron’s Chief Medical Officer David Kerr to Deliver Guest Presentation at WuXi Healthcare Forum 2021 March 1, 2021 Argonaut Therapeutics Announces Appointment of New Board Director Dr Chan Hee Park of JW Pharmaceutical Corporation January 21, 2021 Celleron Therapeutics announces approval of China IND Registration Clinical Trial with partner Nuance Biotech January 20, 2021 Celleron Therapeutics Spins Out SynOx Therapeutics which Secures EUR 37M to Develop Emactuzumab November 30, 2020 Celleron Therapeutics presents at the opening ceremony of BIO-FORUM 2020 held in China September 24, 2020 Celleron Therapeutics enters into a license agreement with Roche to improve the lives of patients living with tenosynovial giant cell tumour August 12, 2020 Argonaut Therapeutics Announces Appointment of New Board Director Nick Dixon-Clegg OSI August 1, 2020 Celleron Therapeutics Chief Medical Officer Prof David Kerr Leads Opening of University of Oxford-Sichuan University Huaxi Joint Centre for Gastrointestinal Cancer May 18, 2020 Celleron Therapeutics’ clinical trial initiated in China with partner Nuance Biotech March 2, 2020 Celleron Therapeutics reports that CXD101 reduces GI side effects of nivolumab January 13, 2020 Celleron Therapeutics announces James Noble as a New Board Member October 21, 2019 Celleron Therapeutics presents CXD101 and nivolumab combination therapy Phase II clinical trial (CAROSELL) at ESMO 2019 September 30, 2019 Celleron Therapeutics to present CXD101 and nivolumab combination therapy Phase II clinical trial (CAROSELL) at ESMO 2019 August 6, 2019 Celleron Therapeutics Data Committee approves continuation of CXD101 and nivolumab combination therapy CAROSELL Phase II clinical trial in MSS CRC patients June 17, 2019 Celleron Therapeutics Presents at the 15th Shanghai International Colorectal Cancer Symposium (SICCS) June 15, 2019 Celleron Therapeutics discusses China as a Biotech Hot Spot, at BioEquity Europe 2019 May 24, 2019 Celleron Therapeutics CXD101 and nivolumab combination therapy CAROSELL clears initial Phase II clinical trial efficacy hurdle in MSS CRC patients April 16, 2019 Celleron Therapeutics announces a new cancer clinical trial of a novel immune combination therapy March 21, 2019 Celleron Therapeutics’ Cake Sale in Support of Comic Relief’s Red Nose Day March 15, 2019 Argonaut Therapeutics Announces Successful Completion of Financing Round March 6, 2019 World Cancer Day: Celleron Therapeutics Commitment to Pioneering Therapies for Cancers February 4, 2019 « Previous 1 2 3 4 Next »
